Back

Applicability of mineralocorticoid receptor antagonist trials to real-world patients with heart failure across the ejection fraction spectrum

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Diagnostic and prognostic biomarkers in heart failure (2) Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Benedikt Norbert Beer

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Digoxin initiation in advanced heart failure with reduced ejection fraction and atrial fibrillation: a nationwide target trial emulation study
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of a pre-discharge checklist on temporal trends in gdmt prescription and clinical events in patients with heart failure
Assistant Professor J. Jang (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Temporal trends and determinants of heart failure therapy after myocardial infarction: a PROFID subanalysis
Doctor A. Sepehri Shamloo (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The prognostic role of a structured patient education programme among patients hospitalised for heart failure with reduced ejection fraction: To know or not to know, that is the question
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
“Hold the drug, strength tomorrow”: The prognostic effect of therapy adherence after a hospitalisation for heart failure with reduced ejection fraction
Doctor P. Schaffer (Budapest, HU)
Abstract Slides

Access the full session

Session thumbnail
Diagnostic and prognostic biomarkers in heart failure (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Eligibility for HFpEF and HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients. Do trial cohorts match with reality?
22 May 2022
thumbnail
Congress Presentation
nsMRAs: what emerging trials tell us about the future of heart failure therapy
18 May 2025
thumbnail
Congress Presentation
ICD in HF: a target trial emulation study
10 May 2026
thumbnail
Congress Presentation
Which patients did recent trials in transthyretin amyloid cardiomyopathy select? - insights from a prospective patient registry
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources